Maven Securities’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
Other funds holding GRCE
OM
Maven Securities's GRCE Position: Q3 2026 in Review
Maven Securities sold out of Grace Therapeutics (GRCE) in Q3 2026, closing a stake of 200,000 shares — an estimated $454K sold.
Maven Securities first reported a position in GRCE in Q2 2026 and held it in 1 quarter. The position peaked at $454K in Q2 2026. 38 funds tracked by Wall St. Rank hold GRCE as of Q3 2026.
- Maven Securities reported no remaining Grace Therapeutics position as of Q3 2026 after selling out during the quarter.
- Maven Securities sold 200,000 Grace Therapeutics shares in Q3 2026, an estimated $454K.
- Maven Securities first reported a position in Grace Therapeutics in Q2 2026 and held it in 1 quarter.
- Maven Securities's Grace Therapeutics position peaked at $454K in Q2 2026.
- 38 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2026.
Based on Maven Securities's 13F filing for Q3 2026, filed 13 Nov 2026.